Validation Data Gallery
|Positive WB detected in
|Raji cells, Ramos cells, mouse thymus tissue
|Positive IP detected in
|Positive IHC detected in
|human colon cancer tissue, human lymphoma tissue
Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0
|Positive IF detected in
|Positive FC detected in
|Western Blot (WB)
|WB : 1:1000-1:6000
|IP : 0.5-4.0 ug for 1.0-3.0 mg of total protein lysate
|IHC : 1:50-1:500
|IF : 1:200-1:800
|Flow Cytometry (FC)
|FC : 0.50 ug per 10^6 cells in a 100 µl suspension
|It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
|Sample-dependent, check data in validation data gallery
25027-1-AP targets RELB in WB, IP, IHC, IF, FC, ELISA applications and shows reactivity with human, mouse samples.
|Host / Isotype
|Rabbit / IgG
|RELB fusion protein Ag13824
|v-rel reticuloendotheliosis viral oncogene homolog B
|Calculated molecular weight
|Observed molecular weight
|GenBank accession number
|Gene ID (NCBI)
|Antigen affinity purification
|PBS with 0.02% sodium azide and 50% glycerol pH 7.3.
|Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA.
RELB, also named as Transcription factor RelB, is a 579 amino acid protein, which contains one RHD domain. RELB localizes in the nucleus and cytoplasm. RELB is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis.
|Product Specific Protocols
|WB protocol for RELB antibody 25027-1-AP
|IHC protocol for RELB antibody 25027-1-AP
|IF protocol for RELB antibody 25027-1-AP
|IP protocol for RELB antibody 25027-1-AP
|FC protocol for RELB antibody 25027-1-AP
|Click here to view our Standard Protocols
Exome sequencing identifies somatic mutations of DDX3X in natural killer/T-cell lymphoma.
Nucleic Acids Res
p38-mediated FOXN3 phosphorylation modulates lung inflammation and injury through the NF-κB signaling pathway
Cell Death Dis
Identification of 11(13)-dehydroivaxillin as a potent therapeutic agent against non-Hodgkin's lymphoma.
J Clin Endocrinol Metab
Circulating Myeloid-derived Suppressor Cells Facilitate Invasion of Thyroid Cancer Cells by Repressing miR-486-3p.
NF-κB fingerprinting reveals heterogeneous NF-κB composition in diffuse large B-cell lymphoma
Chlorogenic Acid Alleviated AFB1-Induced Hepatotoxicity by Regulating Mitochondrial Function, Activating Nrf2/HO-1, and Inhibiting Noncanonical NF-κB Signaling Pathway